BoutetR., & StuartJ. (2000). Assessing the risk of laboratory-acquired meningococcal
disease [Abstract]. Presented at the Neisseria Meningitidis Meeting, Galveston, TX.
2.
CDC. (1991).
Laboratory-acquired meningococcemia—California and
Massachusetts. MMWR, 140, 46–47, 55.
3.
CDC. (1997a).
Case definitions for infectious conditions under public health
surveillance. MMWR, 46 (No. RR-10).
4.
CDC. (1997b)
Immunization of health-care workers: Recommendations of the Advisory
Committee on Immunization Practices and the Hospital Infection Control Practices
Advisory Committee. MMWR, 146 (No. RR-18).
5.
CDC. (1999).
Biosafety in microbiological and biomedical laboratories (4th
ed.). Atlanta, GA: U.S.
Department of Health and Human Services.
6.
CDC. (2000).
Prevention and control of meningococcal disease: Recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR; 49 (No. RR-7).
National Committee for Clinical Laboratory
Standards. (2001). Protection of laboratory workers from
occupationally acquired infections; approved guideline (2nd
ed.). Wayne, PA: National
Committee for Clinical Laboratory Standards, No. M29-A2.
